Trademark: 97035438
Word
HEMGENIX
Status Date
Tuesday, May 16, 2023
Registration Number
7051847
Registration Date
Tuesday, May 16, 2023
Filing Date
Monday, September 20, 2021
Published for Opposition
Tuesday, February 28, 2023
5 Pharmaceutical preparations for use in gene therapy and cell therapy for the treatment of hemophilia
The mark consists of "HEMGENIX" to the right of a helix design.
May 16, 2023
Notice Of Registration Confirmation Emailed
May 16, 2023
Registered-Principal Register
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 20, 2023
Approved For Pub - Principal Register
Jan 19, 2023
Teas/Email Correspondence Entered
Jan 19, 2023
Correspondence Received In Law Office
Jan 19, 2023
Teas Response To Suspension Inquiry Received
Jan 6, 2023
Teas/Email Correspondence Entered
Jan 5, 2023
Correspondence Received In Law Office
Jan 5, 2023
Teas Response To Suspension Inquiry Received
Dec 30, 2022
Notification Of Letter Of Suspension E-Mailed
Dec 30, 2022
Letter Of Suspension E-Mailed
Dec 30, 2022
Suspension Letter Written
Dec 27, 2022
Teas/Email Correspondence Entered
Dec 27, 2022
Correspondence Received In Law Office
Dec 27, 2022
Teas Response To Office Action Received
Jun 27, 2022
Notification Of Non-Final Action E-Mailed
Jun 27, 2022
Non-Final Action E-Mailed
Jun 27, 2022
Non-Final Action Written
Jun 22, 2022
Assigned To Examiner
Oct 26, 2021
Notice Of Design Search Code E-Mailed
Oct 23, 2021
New Application Office Supplied Data Entered
Sep 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
